What to do: Do not consume recalled products to which you are allergic or sensitive.
Audience: General public
Recall class: Class 1
Affected products
Brand
Product
Size
UPC
Codes
Nutrifresh
Falooda Drink with Almond Flavour
290 mL
8 859032 700790
All codes where milk is not declared on the label
Nutrifresh
Falooda Drink with Mango Flavour
290 mL
8 859032 700837
All codes where milk is not declared on the label
Nutrifresh
Falooda Drink with Pistachio Flavour
290 mL
8 859032 700844
All codes where milk is not declared on the label
Nutrifresh
Falooda Drink with Rose Flavour
290 mL
8 859032 700820
All codes where milk is not declared on the label
Issue
The affected products are being recalled from the marketplace because they contain milk which is not declared on the label.
The recalled products have been sold in Alberta, Saskatchewan, Manitoba, Ontario, Quebec, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland and Labrador and may have been distributed in other provinces and territories.
What you should do
Check to see if you have recalled products
Do not consume recalled products to which you are allergic or sensitive as they may cause a serious or life-threatening reaction
Do not serve, use, sell or distribute recalled products
Recalled products should be thrown out or returned to the location where they were purchased
The Foundation Fighting Blindness, the driving force in the global development of treatments and cures for blinding diseases, will host its VISIONS 2024 conference at the Chicago Marriott Downtown Magnificent Mile on June 21?22, 2024. This biennial...
Implicity, a leader in remote patient monitoring and cardiac data management solutions, announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a new groundbreaking algorithm, SignalHF1, used...
The American Trucking Associations is calling attention to the negative consequences for highway safety and safety-sensitive industries that could result from the U.S. Drug Enforcement Administration's proposal to reschedule marijuana from a Schedule...
- AbbVie will present 15 abstracts, including three oral presentations, in Crohn's disease and ulcerative colitis reinforcing AbbVie's commitment to advancing the standards of care in inflammatory bowel diseases (IBD)- Data to be presented from...
We are advised by OsteoStrong that journalists and other readers should disregard the news release, OsteoStrong Celebrates Success and Innovation at 11th Annual Global Franchise Owner Convention, issued May 9, 2024 over PR Newswire.
SOURCE...
Precision BioSciences, Inc. , an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion, excision, and elimination, today...